OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea
· Delayed Price · Currency is KRW 119,600
-2,600 (-2.13%)
At close: Dec 5, 2025
OliX Pharmaceuticals Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 17,283 | 3,883 | 11,983 | 4,930 | 34,337 | 11,329 | Upgrade
|
| Short-Term Investments | 91,900 | - | 10,000 | 53,000 | 15,000 | 55,000 | Upgrade
|
| Trading Asset Securities | 22,272 | 8,531 | 3,942 | 3,941 | 420.68 | 1,782 | Upgrade
|
| Cash & Short-Term Investments | 131,455 | 12,414 | 25,925 | 61,872 | 49,757 | 68,111 | Upgrade
|
| Cash Growth | 1007.85% | -52.11% | -58.10% | 24.35% | -26.95% | 91.64% | Upgrade
|
| Accounts Receivable | 28.58 | 0 | 3,558 | 53.23 | - | - | Upgrade
|
| Other Receivables | 599.5 | 907.84 | 1,419 | 996.88 | 272.13 | 159.18 | Upgrade
|
| Receivables | 628.08 | 907.84 | 4,977 | 1,050 | 491.49 | 446.57 | Upgrade
|
| Inventory | 455.77 | 554.26 | 468.41 | 657.17 | 374.13 | 304.17 | Upgrade
|
| Prepaid Expenses | 1,316 | 1,370 | 244.9 | 1,367 | 1,480 | 7.13 | Upgrade
|
| Other Current Assets | 42.5 | 287.98 | 526.86 | 99 | 136.92 | 178.26 | Upgrade
|
| Total Current Assets | 133,898 | 15,534 | 32,142 | 65,046 | 52,240 | 69,047 | Upgrade
|
| Property, Plant & Equipment | 49,495 | 51,385 | 43,910 | 37,232 | 31,525 | 6,180 | Upgrade
|
| Long-Term Investments | 796.77 | 1,986 | 23,481 | 26,809 | 0.5 | 0.45 | Upgrade
|
| Other Intangible Assets | 1,929 | 1,705 | 1,981 | 2,107 | 2,134 | 2,529 | Upgrade
|
| Other Long-Term Assets | 461.29 | 639.62 | 1,312 | 1,458 | 772.05 | 820.53 | Upgrade
|
| Total Assets | 186,580 | 71,249 | 102,825 | 132,651 | 86,672 | 78,577 | Upgrade
|
| Accrued Expenses | 301.33 | 488.52 | 465.36 | 358.62 | 297.85 | 80.04 | Upgrade
|
| Short-Term Debt | 644 | 13,441 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 3,571 | 3,572 | - | 19,230 | 16,405 | - | Upgrade
|
| Current Portion of Leases | 185.81 | 745.85 | 1,065 | 939.87 | 487.8 | 258.63 | Upgrade
|
| Current Income Taxes Payable | 6.42 | 53.77 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 12,883 | 11,759 | 5,033 | 19,014 | 23,174 | 4,150 | Upgrade
|
| Total Current Liabilities | 17,592 | 30,060 | 6,563 | 39,543 | 40,365 | 4,488 | Upgrade
|
| Long-Term Debt | 18,750 | 21,428 | 35,362 | 20,000 | 20,326 | 14,011 | Upgrade
|
| Long-Term Leases | - | 5.38 | 2,930 | 3,826 | 51.69 | 257 | Upgrade
|
| Pension & Post-Retirement Benefits | 1,005 | 414.47 | - | - | 225.41 | 225.59 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | - | 1,647 | Upgrade
|
| Other Long-Term Liabilities | 6,675 | 867.98 | 7,634 | 3,080 | 6,296 | 12,597 | Upgrade
|
| Total Liabilities | 44,022 | 52,777 | 52,489 | 66,449 | 67,265 | 33,227 | Upgrade
|
| Common Stock | 10,057 | 9,230 | 8,010 | 6,852 | 6,852 | 6,771 | Upgrade
|
| Additional Paid-In Capital | 330,680 | 175,533 | 157,177 | 151,895 | 92,908 | 91,128 | Upgrade
|
| Retained Earnings | -206,045 | -167,785 | -122,910 | -103,224 | -84,303 | -54,379 | Upgrade
|
| Comprehensive Income & Other | 6,195 | 871.87 | 7,141 | 8,885 | 3,064 | 1,765 | Upgrade
|
| Total Common Equity | 140,888 | 17,849 | 49,418 | 64,407 | 18,521 | 45,286 | Upgrade
|
| Minority Interest | 681.25 | 623.76 | 481.45 | 295.16 | 886.27 | 65.31 | Upgrade
|
| Shareholders' Equity | 142,559 | 18,473 | 50,336 | 66,203 | 19,407 | 45,351 | Upgrade
|
| Total Liabilities & Equity | 186,580 | 71,249 | 102,825 | 132,651 | 86,672 | 78,577 | Upgrade
|
| Total Debt | 23,151 | 39,192 | 39,357 | 43,996 | 37,271 | 14,527 | Upgrade
|
| Net Cash (Debt) | 108,304 | -26,778 | -13,433 | 17,876 | 12,487 | 53,584 | Upgrade
|
| Net Cash Growth | - | - | - | 43.16% | -76.70% | 51.72% | Upgrade
|
| Net Cash Per Share | 5703.21 | -1589.86 | -930.93 | 1304.50 | 912.36 | 4074.15 | Upgrade
|
| Filing Date Shares Outstanding | 20.01 | 18.46 | 16.02 | 13.7 | 13.7 | 13.54 | Upgrade
|
| Total Common Shares Outstanding | 20.01 | 18.46 | 16.02 | 13.7 | 13.7 | 13.54 | Upgrade
|
| Working Capital | 116,306 | -14,526 | 25,578 | 25,502 | 11,874 | 64,559 | Upgrade
|
| Book Value Per Share | 7040.71 | 966.92 | 3084.79 | 4700.19 | 1351.59 | 3344.07 | Upgrade
|
| Tangible Book Value | 138,958 | 16,144 | 47,437 | 62,300 | 16,387 | 42,756 | Upgrade
|
| Tangible Book Value Per Share | 6944.29 | 874.55 | 2961.16 | 4546.39 | 1195.84 | 3157.30 | Upgrade
|
| Land | 25,325 | 25,460 | 25,740 | 25,740 | 25,740 | 988.21 | Upgrade
|
| Buildings | 22,687 | 23,033 | 3,354 | 3,354 | 3,354 | 3,115 | Upgrade
|
| Machinery | 7,468 | 7,425 | 6,436 | 5,518 | 4,427 | 3,330 | Upgrade
|
| Construction In Progress | 25.8 | - | 8,948 | 1,239 | 71.73 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.